AndreyPopov Shares of pharmaceutical company, Aquestive Therapeutics (NASDAQ:AQST) jumped 137.29% (YoY) after the Food and Drug Administration (FDA) approved rival company ARS Pharmaceuticals' (SPRY) "epinephrine nasal spray" also called Neffy. This drug is the first nasal spray to be authorized for emergency allergic reactions (anaphylaxis) giving a substitute to auto-injectors known as EpiPens. In this article, I will explain why this is the right time to buy AQST stock due to the company's robust res ...